(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one

C26H33F3N2O3 — CID 124894540

IUPAC(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
SMILESC[C@@H]1CC[C@@H]2[C@H](CN3CCN(c4cccc(C(F)(F)F)c4)CC3)C(=O)O[C@]23[C@@H]1CC[C@@]1(C)O[C@@H]31
InChIInChI=1S/C26H33F3N2O3/c1-16-6-7-21-19(22(32)33-25(21)20(16)8-9-24(2)23(25)34-24)15-30-10-12-31(13-11-30)18-5-3-4-17(14-18)26(27,28)29/h3-5,14,16,19-21,23H,6-13,15H2,1-2H3/t16-,19+,20-,21-,23-,24-,25-/m1/s1
InChIKeyLSDFDNALGJDQTF-KCTOCKSFSA-N
MW478.56 g/mol
LogP4.35
Rot. Bonds3

About (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one

(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one (PubChem CID 124894540) has the molecular formula C26H33F3N2O3 and a molecular weight of 478.56 g/mol. Its IUPAC name is (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one.

Molecular Properties

Compound Name(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
PubChem CID124894540
Molecular FormulaC26H33F3N2O3
Molecular Weight478.56 g/mol
Exact Mass478.24
IUPAC Name(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
SMILESC[C@@H]1CC[C@@H]2[C@H](CN3CCN(c4cccc(C(F)(F)F)c4)CC3)C(=O)O[C@]23[C@@H]1CC[C@@]1(C)O[C@@H]31
InChIInChI=1S/C26H33F3N2O3/c1-16-6-7-21-19(22(32)33-25(21)20(16)8-9-24(2)23(25)34-24)15-30-10-12-31(13-11-30)18-5-3-4-17(14-18)26(27,28)29/h3-5,14,16,19-21,23H,6-13,15H2,1-2H3/t16-,19+,20-,21-,23-,24-,25-/m1/s1
InChIKeyLSDFDNALGJDQTF-KCTOCKSFSA-N
XLogP4.35
TPSA45.31 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.56
LogP ≤ 54.35
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The IUPAC name of (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one (CID 124894540) is (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one.
What is the SMILES notation for (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The canonical SMILES for (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one is C[C@@H]1CC[C@@H]2[C@H](CN3CCN(c4cccc(C(F)(F)F)c4)CC3)C(=O)O[C@]23[C@@H]1CC[C@@]1(C)O[C@@H]31.
What is the InChIKey of (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
The InChIKey is LSDFDNALGJDQTF-KCTOCKSFSA-N. The full InChI is InChI=1S/C26H33F3N2O3/c1-16-6-7-21-19(22(32)33-25(21)20(16)8-9-24(2)23(25)34-24)15-30-10-12-31(13-11-30)18-5-3-4-17(14-18)26(27,28)29/h3-5,14,16,19-21,23H,6-13,15H2,1-2H3/t16-,19+,20-,21-,23-,24-,25-/m1/s1.
What are the key properties of (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one?
(1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one has a molecular weight of 478.56 g/mol, XLogP of 4.35, 3 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,4R,5R,8R,9R,12R,14R)-8,12-dimethyl-4-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one is sourced from PubChem (CID 124894540), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).